Coenzyme M
Coenzyme M structure
|
Common Name | Coenzyme M | ||
|---|---|---|---|---|
| CAS Number | 45127-11-5 | Molecular Weight | 282.379 | |
| Density | 1.8±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C4H10O6S4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 2-(2-sulfoethyldisulfanyl)ethanesulfonic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Molecular Formula | C4H10O6S4 |
| Molecular Weight | 282.379 |
| Exact Mass | 281.936005 |
| PSA | 176.10000 |
| LogP | -1.83 |
| Index of Refraction | 1.637 |
| HS Code | 2930909090 |
|---|
|
~97%
Coenzyme M CAS#:45127-11-5 |
| Literature: Huang, Qiuli; Kochat, Harry; Chen, Xinghai Patent: US2006/63949 A1, 2006 ; Location in patent: Page/Page column 2 ; |
|
~%
Coenzyme M CAS#:45127-11-5 |
| Literature: Danehy,J.P.; Hunter,W.E. Journal of Organic Chemistry, 1967 , vol. 32, # 7 p. 2047 - 2053 |
|
~%
Coenzyme M CAS#:45127-11-5 |
| Literature: Fedoseyeva,V.N.; Petrun'kin,V.E. Sov. Prog. Chem. (Engl. Transl.), 1967 , vol. 33, # 6 p. 596 - 597,57 - 58 |
|
~%
Coenzyme M CAS#:45127-11-5 |
| Literature: Lemaire,H.; Rieger,M. Journal of Organic Chemistry, 1961 , vol. 26, p. 1330 - 1331 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2930909090 |
|---|---|
| Summary | 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.
Cancer Chemother. Pharmacol. 67(2) , 381-91, (2011) Previous studies from our laboratory have identified a role for gamma-glutamyl transpeptidase (GGT) in BNP7787 (disodium 2,2'-dithio-bis ethane sulfonate, dimesna, Tavocept™)-mediated cisplatin nephro... |
|
|
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
J. Thorac. Oncol. 3(10) , 1159-65, (2008) We investigated dose-dense docetaxel and cisplatin in patients with measurable non-small cell lung cancer in a randomized phase II study without [A] or with [B] a putative chemoprotective agent, BNP77... |
|
|
New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
Cancer Chemother. Pharmacol. 52 Suppl 1 , S3-15, (2003) Any approach applied to drug discovery and development by the medical community and pharmaceutical industry has a direct impact on the future availability of improved, novel, and curative therapies fo... |
| Ethanesulfonic acid, 2,2'-dithiobis- |
| 2,2'-Dithiodiethanesulfonic acid |
| 2,2'-dithiobisethanesulfonic acid |
| Ethanesulfonic acid,2,2'-dithiobis |
| 2,2'-Disulfanediyldiethanesulfonic acid |
| Coenzyme |